ArticleNature communications2026
De novo-designed ribozyme-controlled riboregulator for cell-free diagnostics.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- De novo-designed ribozyme-controlled riboregulator for cell-free diagnostics.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Cell-free systems have great potential for nucleic acid assays, yet universal onsite diagnostics without preamplification are limited. Here, a universal cell-free diagnostic platform termed TRACKer (Target-Responsive non-preAmplification Cell-free diagnostic Kit) has been developed for detecting multiple respiratory viral RNAs in laboratory and field settings. TRACKer integrates three modules: ribozyme allostery module, riboregulator activation module, and output module. The ribozyme allostery module enables universal target recognition through strand displacement-mediated ribozyme conformational switching. The riboregulator activation module achieves preamplification-free detection via cascade expression of reporter proteins. The output module provides swappable reporter templates for luminescent quantification and lateral flow visualization in diverse scenarios. TRACKer is a robust system that enables rapid ( < 70 min) nucleic acid detection without preamplification and demonstrates attomolar sensitivity (1-10 aM) for six respiratory viruses. Overall, TRACKer presents a promising approach to nucleic acid detection, offering a low-cost and scalable solution with potential applications in point-of-care diagnostics and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.